DSGN · Categories · Form 3
DSGN - SEC Form 3 initial insider statements
Design Therapeutics Inc. (DSGN) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for DSGN
- SEC Form 3 filed by new insider Shapiro David3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3 filed by new insider Gover Justin D.3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3 filed by new insider Storgard Chris3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3 filed by new insider Dunham Trust Co3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- New insider Kim Jae B. claimed ownership of 4,756 shares (SEC Form 3)3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3 filed by new insider Burgess Julie3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3: Giangiulio Dawn claimed ownership of 7,500 units of Common Stock3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3: Prasad Deepa claimed ownership of 1,817,273 units of Common Stock3 - Design Therapeutics, Inc. (0001807120) (Issuer)
- SEC Form 3 filed by Behanna Heather3 - Design Therapeutics, Inc. (0001807120) (Issuer)